| D07CA - Corticosteroids, Weak, Combinations with Antibiotics | ATC-DDD Version 2016. Source: WHO | | D - Dermatologicals | Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.
| Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.
|
| | D07 - Corticosteroids, Dermatological Preparations | As a main rule, all topical corticosteroid preparations should be classified in this group. There are, however, some few exceptions:
Combinations of corticosteroids and antiinfectives for gynaecological use, see G01B.
Corticosteroids for local oral treatment, see A01AC.
Corticosteroids in combination with antifungals are classified in D01A.
Anti-acne preparations, see D10A.
Antihemorrhoidals with corticosteroids, see C05AA.
Corticosteroids for ophthalmological or otological use, see S - Sensory organs.
|
| | D07C - Corticosteroids, Combinations with Antibiotics | This group comprises combined corticosteroid/antibiotic preparations for dermatological use. The group is subdivided according to clinical potency, see D07A. Exceptions, see D07.
At each 5th level various antibiotics may occur.
Combinations of corticosteroids, gentamicin and imidazole and triazole derivatives are classified here. Combinations of corticosteroids and imidazole and triazole derivatives are classified in D01AC - Imidazole and triazole derivatives.
|
| | D07CA - Corticosteroids, Weak, Combinations with Antibiotics | | |
|
|
|
